Total Funding
51
46
Total FundingPre-Seed raised
Growth Score 51 in past quarter
-6 pts
Heat Score 46 in past quarter
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
55229
Farcast develops a diagnostic platform that delivers powerful predictions for personalized cancer treatment selection and drug development.
- Terry Brady: Chief Financial Officer
Mallik Sundaram: Founder and DirectorPast Role: Mitra Biotech, President & CEO
About the Company
Farcast is a clinical diagnostic company whose mission it is to illuminate personal treatment truth of a cancer patient. The Farcast technology core is a human tumor micro-environment that enables oncologists and drug developers to test individual tumors to determine treatment response profiles. The company has its headquarters in Boston in
Massachusetts, and operates a lab in Bangalore in India.